I now have comprehensive data. Here is the complete answer:
Injectable Drugs for Respiratory Wheezing
Wheezing indicates airway narrowing (bronchospasm). The cause determines the injectable drug of choice - acute severe asthma, COPD exacerbation, and anaphylaxis are the most common emergencies requiring injectables.
1. Epinephrine (Adrenaline) - FIRST LINE for Anaphylaxis / Severe Bronchospasm
The most potent bronchodilator available. Acts on beta-2 receptors to relax bronchial smooth muscle AND on alpha receptors to reduce mucosal edema.
| Route | Concentration | Dose | Indication |
|---|
| IM (thigh) | 1:1000 (1 mg/mL) | 0.01 mg/kg up to 0.5 mg | Anaphylaxis - FIRST LINE |
| SC | 1:1000 (1 mg/mL) | 0.01 mg/kg; max 0.5 mg (adult); 0.3 mg (child) | Severe asthma if no IV access |
| IV | 1:10,000 (0.1 mg/mL) | 0.1-0.25 mg slow IV over 5-10 min, repeat q5-15 min; or 0.001 mg/kg bolus then 0.1-1 mcg/kg/min infusion | Refractory anaphylaxis / cardiac arrest |
Key points:
- IM into the outer thigh is faster and more reliable than SC for anaphylaxis
- IV epinephrine carries risk of lethal arrhythmia - cardiac monitoring mandatory
- Standard EpiPen dose for adults: 0.5 mg IM
- Repeat IM dose up to twice if needed
Rosen's Emergency Medicine, Harriet Lane Handbook 23e, Red Book 2021
2. Terbutaline (SC / IV) - Beta-2 Selective Agonist
Preferred parenteral beta-2 agonist when inhaled therapy is insufficient (minimal air entry, severe bronchospasm, intubated patient).
| Route | Dose |
|---|
| SC | 0.01 mg/kg/dose (max 0.25 mg); q20 min x 3 doses then q2-6h |
| IV loading | 4-10 mcg/kg IV over 10-20 min |
| IV infusion | 0.1-10 mcg/kg/min (titrated to effect) |
Advantages over epinephrine: More beta-2 selective, safer cardiac profile, preferred in asthma without anaphylaxis.
Indication: Severe acute asthma with minimal air entry; IV administration may decrease need for mechanical ventilation.
Harriet Lane Handbook 23e, Miller's Anesthesia 10e, Katzung's Pharmacology 16e
3. IV Magnesium Sulfate - Severe Refractory Bronchospasm
Mechanism: Calcium channel blocker - relaxes bronchial smooth muscle. Also has some anti-inflammatory effect.
| Population | Dose | Rate |
|---|
| Adults | 1-2 g IV | Over 20-30 minutes |
| Children | 25-75 mg/kg IV (max 2 g) | Over 20 minutes |
When to use:
- Severe acute asthma (FEV1 / PEFR < 25% predicted) refractory to standard bronchodilators
- Patients not responding to inhaled beta-2 agonists + corticosteroids after 1 hour
- NOT routinely recommended in COPD (evidence does not support standard use)
Side effects (dose-related): Flushing, warmth, sweating, nausea, muscle weakness, hypotension, cardiac arrhythmias, respiratory depression.
Tintinalli's Emergency Medicine, Washington Manual, Fishman's Pulmonary Diseases, Harriet Lane Handbook
4. Systemic Corticosteroids (IV / IM)
Reduce airway inflammation; effect takes 4-6 hours to begin but reduces relapse and length of stay.
| Drug | IV / IM Dose | Notes |
|---|
| Methylprednisolone | 125 mg IV (adults); 1-2 mg/kg IV (children) | Most commonly used IV steroid |
| Hydrocortisone | 100-200 mg IV q4-6h | Equivalent option |
| Dexamethasone | 0.15-0.6 mg/kg PO/IV/IM | Single dose; equal efficacy to 5-day prednisone |
Key points:
- IV and oral are equally effective if patient can swallow
- Use IV only if patient cannot tolerate oral or is in severe shock
- Short 5-day course recommended (no benefit to longer courses)
- Main side effect: hyperglycemia (monitor blood glucose)
Rosen's Emergency Medicine, Harriet Lane Handbook 23e, Tintinalli's Emergency Medicine
5. Aminophylline (IV Methylxanthine) - Third/Last Line
| Population | Loading Dose | Maintenance Infusion |
|---|
| Adults | 3-5 mg/kg IV over 30 min | 0.5 mg/kg/hr |
| Children | 6 mg/kg IV over 20 min | 0.5-1.2 mg/kg/hr (age-dependent) |
Mechanism: Phosphodiesterase inhibition → bronchodilation + improved respiratory drive + diaphragmatic contractility
Important caveats:
- Last-line option - not superior to nebulized beta-2 agonists
- Narrow therapeutic window; toxic levels cause nausea, tachycardia, seizures, arrhythmias
- If patient is already on oral theophylline: halve the loading dose + check plasma levels
- Low-dose theophylline also sensitizes corticosteroid receptors (reverses steroid resistance)
Goodman & Gilman's Pharmacological Basis of Therapeutics, Harriet Lane Handbook 23e, Fishman's Pulmonary Diseases
6. Ketamine (IV) - Bronchodilator + RSI Agent
Dose: 1-2 mg/kg IV loading, then 1 mg/kg/hr infusion
Mechanism: Catecholamine release + direct smooth muscle relaxation → bronchodilation
When to use:
- Status asthmaticus refractory to all conventional therapy
- Drug of choice for RSI/intubation in severe asthma (bronchodilates while inducing anesthesia)
- NOT effective as a sole bronchodilator - secondary/adjunct agent
Caution: Increases salivation (may cause laryngospasm), increases ICP, causes emergence reactions.
Tintinalli's Emergency Medicine, Miller's Anesthesia 10e, Barash Clinical Anesthesia 9e
7. Diphenhydramine (IV/IM) - Anaphylaxis-Related Wheezing
Dose: 1-2 mg/kg IV/IM (max 50 mg/dose)
Antihistamine adjunct in anaphylaxis; does NOT replace epinephrine. Used for urticaria + mild allergic wheeze as secondary therapy.
Quick Reference Summary by Severity
| Severity | Injectable Drug(s) of Choice |
|---|
| Anaphylaxis + wheezing | Epinephrine IM 0.5 mg (FIRST LINE) + IV corticosteroid + antihistamine |
| Acute severe asthma | IV/IM methylprednisolone + IV MgSO4 + SC/IV terbutaline if inhaled fails |
| Status asthmaticus (refractory) | IV terbutaline infusion + IV ketamine + IV aminophylline |
| Pre-intubation / RSI | Ketamine IV 1-2 mg/kg (drug of choice in asthma) |
| COPD exacerbation | IV methylprednisolone (if oral not feasible) + IV antibiotics |
Sources: Tintinalli's Emergency Medicine, Rosen's Emergency Medicine, Miller's Anesthesia 10e, Harriet Lane Handbook 23e, Goodman & Gilman's Pharmacological Basis of Therapeutics, Fishman's Pulmonary Diseases, Washington Manual of Medical Therapeutics